Driehaus Capital Management’s Idexx Laboratories IDXX Stock Holding History

Driehaus Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-991	Closed	-$273K	–	524
2019 Q2	$273K	Sell	991 -55	-5%	-$13.6K	0.01%	424
2019 Q1	$234K	Buy	+1,046	New	+$216K	0.01%	374
2018 Q4	–	Sell	-6,351	Closed	-$1.59M	–	459
2018 Q3	$1.59M	Sell	6,351 -1,181	-16%	-$287K	0.05%	309
2018 Q2	$1.64M	Buy	7,532 +2,129	+39%	+$439K	0.06%	294
2018 Q1	$1.03M	Buy	+5,403	New	+$997K	0.04%	346
2017 Q4	–	Sell	-3,845	Closed	-$598K	–	569
2017 Q3	$598K	Sell	3,845 -658	-15%	-$104K	0.02%	370
2017 Q2	$727K	Sell	4,503 -50	-1%	-$8.12K	0.03%	379
2017 Q1	$704K	Buy	+4,553	New	+$628K	0.02%	403
2016 Q4	–	Sell	-5,553	Closed	-$626K	–	592
2016 Q3	$626K	Buy	+5,553	New	+$585K	0.02%	408
2014 Q3	–	Sell	-66,980	Closed	-$4.47M	–	574
2014 Q2	$4.47M	Buy	+66,980	New	+$4.26M	0.15%	198

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Driehaus Capital Management's IDXX Position: Q3 2019 in Review

Driehaus Capital Management sold out of Idexx Laboratories (IDXX) in Q3 2019, closing a stake of 991 shares — an estimated $273K sold.

Driehaus Capital Management first reported a position in IDXX in Q2 2014 and held it in 10 quarters. The position peaked at $4.47M in Q2 2014. 720 funds tracked by Wall St. Rank hold IDXX as of Q3 2019.

Driehaus Capital Management reported no remaining Idexx Laboratories position as of Q3 2019 after selling out during the quarter.
Driehaus Capital Management sold 991 Idexx Laboratories shares in Q3 2019, an estimated $273K.
Driehaus Capital Management first reported a position in Idexx Laboratories in Q2 2014 and held it in 10 quarters.
Driehaus Capital Management's Idexx Laboratories position peaked at $4.47M in Q2 2014.
720 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2019.

Based on Driehaus Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.